Tate Jeffrey
- SEC CIK
- 0001499075
No open-market purchases or sales filed in the past year.
Current role at each company
- CYTH Cyclo Therapeutics, Inc.Chief Operating Officeras of Jun 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Tate Jeffrey as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2023 (view filing)6:06 AM ET | Oct 20 | 3 days | Tate JeffreyChief Operating Officer | PPurchase | +32.9K | – | – | –32.9K after | Derivative |
| Apr 24, 2023 (view filing)11:00 AM ET | Apr 20 | 4 days | Tate JeffreyChief Operating Officer | PPurchase | +29.9K | $0.71 | +$21.3K | +93.1%62.1K after | |
| Apr 24, 2023 (view filing)11:00 AM ET | Apr 20 | 4 days | Tate JeffreyChief Operating Officer | PPurchase | +29.9K | $0.125 | +$3.74K | –29.9K after | Derivative |
| May 16, 2022 (view filing) | May 16 | Same day | Tate JeffreyChief Operating Officer | PPurchase | +3.00K | $2.12 | +$6.36K | +10.3%32.2K after | |
| Apr 29, 2022 (view filing) | Apr 28-29 | 1 day | Tate JeffreyChief Operating Officer | PPurchase | +2.00K | $2.64 | +$5.28K | +7.4%29.2K after | 3 lots |